Clopidogrel+Aspirin Tablets

Free

Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

Clopidogrel + Aspirin Tablets

Healthy Inc is a specialized global supplier and exporter of life-saving cardiovascular fixed-dose combinations (FDCs). We provide high-stability Clopidogrel Bisulfate & Aspirin Tablets, sourced from WHO–GMP certified solid dosage facilities. This “Stent Guardian” is a top export to interventional cardiology units, cath labs, and government health ministries in Africa, LATAM, and Southeast Asia, serving as the gold-standard Dual Antiplatelet Therapy (DAPT) for the prevention of stent thrombosis and recurrent heart attacks.


Product Overview

This formulation contains a synergistic combination of two potent antiplatelet agents targeting distinct pathways of blood clotting.

The “Dual-Pathway” Specialist:

  • Mechanism (Clopidogrel): It is a thienopyridine prodrug that selectively and irreversibly inhibits the binding of Adenosine Diphosphate (ADP) to its platelet P2Y12 receptor. This prevents the activation of the GPIIb/IIIa complex, the major receptor for fibrinogen.
  • Mechanism (Aspirin): Acetylsalicylic Acid irreversibly inhibits the enzyme Cyclooxygenase-1 (COX-1), thereby preventing the synthesis of Thromboxane A2 (TXA2), a potent vasoconstrictor and platelet aggregator.
  • Synergy (DAPT): By blocking two independent pathways of platelet activation (ADP and TXA2), the combination provides superior protection against thrombotic events (clots) compared to either drug alone, especially in high-risk patients with metal or drug-eluting stents.

Product Composition & Strength

We supply this product as Enteric Coated or Bilayer Tablets (typically Pink/Red or White). The formulation is critical to protect the stomach from Aspirin and prevent chemical interaction between the two actives.

Active Ingredient Strength (Standard) Therapeutic Role
Clopidogrel Bisulfate USP/BP 75 mg ADP Receptor Blocker
Aspirin (Acetylsalicylic Acid) USP/BP 75 mg / 150 mg COX-1 Inhibitor
Excipients Q.S. Methacrylic Acid Copolymer / Hydrogenated Oil Enteric Coating / Stabilizer

*Pack Sizes: Blister packs of 10s (Box of 10×10), 14s, 15s (Calendar Pack), or Bulk HDPE Jars of 500s.


Technical & Logistics Specifications

Critical data for Pharmaceutical Importers and Distributors.

HS Code 3004.90.99 (Other Medicaments)
Dosage Form Tablet (Enteric Coated / Bilayer)
Packaging Alu-Alu Blister (Hydrolysis Sensitive)
Storage Store below 25°C. Protect strictly from Moisture.
Certificates WHO-GMP, COPP, Free Sale Certificate

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

  • Hydrolysis Prevention: Aspirin is highly sensitive to moisture and degrades into Salicylic Acid (smelling of vinegar) and Acetic Acid, which can then degrade the Clopidogrel. We use Alu-Alu (Cold Form) packaging and specialized “Low Moisture” manufacturing suites to ensure a 24-month stable shelf life.
  • Enteric Coating: To minimize the risk of gastric ulcers caused by Aspirin, our Aspirin component is enteric-coated to dissolve only in the intestine, protecting the stomach lining.

Therapeutic Indications (Human Use)

Indicated for the secondary prevention of atherothrombotic events:

  • Acute Coronary Syndrome (ACS): For patients with Unstable Angina or Non-ST-Elevation Myocardial Infarction (NSTEMI).
  • Post-PCI (Stenting): Mandatory therapy after Percutaneous Coronary Intervention to prevent Stent Thrombosis (clotting inside the stent).
  • Recent MI / Stroke: Prevention of recurrent heart attack or ischemic stroke in high-risk patients.

Dosage & Administration

Recommended Dosage (Strictly as per Cardiologist):

  • Route: Oral.
  • Maintenance Dose: One tablet (75mg + 75mg) once daily.
  • Loading Dose: Often preceded by a loading dose of separate tablets (e.g., 300mg/600mg Clopidogrel + 300mg Aspirin) in acute settings.
  • Duration: Typically 12 months post-stenting (DAPT duration), or longer based on bleeding risk.
  • Administration: Take with food to further reduce gastric irritation.

Safety Warnings:

  • Bleeding Risk (BLACK BOX WARNING): Increases the risk of bleeding (gastrointestinal, intracranial). Discontinue 5-7 days before any elective surgery (including dental work) to allow platelet function to restore.
  • PPI Interaction: Omeprazole may reduce the antiplatelet effect of Clopidogrel (CYP2C19 inhibition). Pantoprazole is generally preferred if gastric protection is needed.
  • Hypersensitivity: Do not use if allergic to NSAIDs or Aspirin (Asthma risk).

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for OSD (Oral Solid Dosage) forms, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for government procurement in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.

Reviews

There are no reviews yet.

Be the first to review “Clopidogrel+Aspirin Tablets”

Your email address will not be published. Required fields are marked *